1. Home
  2. SLNG vs ANVS Comparison

SLNG vs ANVS Comparison

Compare SLNG & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

N/A

Current Price

$4.96

Market Cap

119.0M

Sector

Utilities

ML Signal

N/A

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

N/A

Current Price

$1.12

Market Cap

76.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLNG
ANVS
Founded
2013
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
76.6M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
SLNG
ANVS
Price
$4.96
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.00
$13.50
AVG Volume (30 Days)
41.9K
1.1M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
39.39
EPS
N/A
N/A
Revenue
$68,245,000.00
N/A
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.21
$1.10
52 Week High
$7.07
$5.50

Technical Indicators

Market Signals
Indicator
SLNG
ANVS
Relative Strength Index (RSI) 42.02 21.89
Support Level $4.95 N/A
Resistance Level $5.61 $2.02
Average True Range (ATR) 0.51 0.10
MACD -0.17 -0.06
Stochastic Oscillator 3.30 3.29

Price Performance

Historical Comparison
SLNG
ANVS

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: